GI
VNDA icon

GAMMA Investing’s Vanda Pharmaceuticals VNDA Stock Holding History

GAMMA Investing’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.86K Buy
2,008
+1,718
+592% +$9.23K ﹤0.01% 3341
2026
Q2 		$1.77K Sell
290
-261
-47% -$1.71K ﹤0.01% 3753
2026
Q1 		$3.81K Buy
551
+368
+201% +$2.84K ﹤0.01% 3471
2025
Q4 		$1.61K Buy
183
+120
+190% +$660 ﹤0.01% 3668
2025
Q3 		$314 Hold
63
– – ﹤0.01% 3761
2025
Q2 		$297 Buy
+63
New +$275 ﹤0.01% 3698
2025
Q1 		– Sell
-32
Closed -$153 – 3886
2024
Q4 		$153 Sell
32
-166
-84% -$797 ﹤0.01% 3729
2024
Q3 		$929 Sell
198
-38
-16% -$204 ﹤0.01% 3277
2024
Q2 		$1.33K Buy
+236
New +$1.22K ﹤0.01% 2994

Other funds holding VNDA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
CFS
CGC Financial Services Lake Oswego, Oregon $451M AUM 11.72% 1-Year Est. Return

GAMMA Investing's VNDA Position: Q3 2026 in Review

GAMMA Investing increased its Vanda Pharmaceuticals (VNDA) stake by 592% in Q3 2026, buying an estimated $9.23K and bringing the position to 2,008 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3341.

GAMMA Investing first reported a position in VNDA in Q2 2024 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • GAMMA Investing held 2,008 shares of Vanda Pharmaceuticals worth $9.86K as of Q3 2026.
  • GAMMA Investing bought 1,718 Vanda Pharmaceuticals shares in Q3 2026, an estimated $9.23K.
  • Vanda Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3341 holding.
  • GAMMA Investing first reported a position in Vanda Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.